• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

11 more hcv reps are quitting in the next month!













TGIF!! I probably haven't generated a script for our "pre-launch" POS this week. But that's OK because I am getting paid to do nothing. Good gig to say the least. My DM spends her time in the gym and spa an touches bases occasionally. All is Good Lutzy!
 








TGIF!! I probably haven't generated a script for our "pre-launch" POS this week. But that's OK because I am getting paid to do nothing. Good gig to say the least. My DM spends her time in the gym and spa an touches bases occasionally. All is Good Lutzy!

Touches bases? Wow, now that is an engaged manager in a pretend sales forces out "qualifying accounts". What a fucking joke. Paid over $140k to orbit Louie and create busy work.

Gilead sold another $4B of their product. When we launch, they will have sold over $10B. That is equal to HUMIRA annual us sales. Wow.

Touches bases? No, it is not funny.